Lenvatinib is now listed in the interaction checker as a cancer drug and interactions can be found with all the comedications.
Lenvatinib (Lenvima®, Kisplyx®) is a tyrosine kinase inhibitor and is indicated for the treatment of thyroid neoplasms and renal cell carcinoma.
